Latest Period
Q1 2026
CUSIP: 89788C104
Latest Period
Q1 2026
Institutions Reporting
5
Shares (Excl. Options)
185,304
Price
$5.60
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 5 institutions filings for Q1 2026.
What is CUSIP 89788C104?
CUSIP 89788C104 identifies TCNNF - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 89788C104:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Marex Securities Products Inc. | 5.8% | $51,675,000 | 9,750,000 | Marex Securities Products Inc. | 16 Dec 2025 |
As of 31 Mar 2026, 5 institutional investors reported holding 185,304 shares of Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF). This represents 0.11% of the company’s total 168,103,448 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 185,304 | $1,037,923 | +$176,819 | $5.60 | 5 |
| 2025 Q4 | 153,603 | $1,334,814 | -$101,646 | $8.69 | 7 |
| 2025 Q3 | 53,669 | $432,747 | +$8,060 | $8.06 | 7 |
| 2025 Q2 | 52,669 | $200,245 | +$1,482 | $3.80 | 7 |
| 2025 Q1 | 52,279 | $201,755 | -$4,348 | $3.86 | 6 |
| 2024 Q4 | 53,379 | $277,327 | -$10,457 | $5.18 | 7 |
| 2024 Q3 | 48,323 | $588,415 | -$108,570 | $12.20 | 7 |
| 2024 Q2 | 57,208 | $529,093 | +$78,104 | $9.25 | 6 |
| 2024 Q1 | 48,725 | $604,270 | -$95,304 | $12.47 | 4 |
| 2023 Q4 | 56,530 | $294,126 | -$165,277 | $5.21 | 5 |
| 2023 Q3 | 82,111 | $500,513 | +$88,809 | $6.09 | 7 |
| 2023 Q2 | 67,581 | $264,944 | -$275,506 | $3.93 | 8 |
| 2023 Q1 | 111,664 | $632,640 | +$209,473 | $5.59 | 10 |
| 2022 Q4 | 89,995 | $682,647 | -$155,867 | $7.60 | 10 |
| 2022 Q3 | 101,903 | $867,476 | -$1,934,643 | $8.51 | 8 |
| 2022 Q2 | 268,111 | $3,093,000 | -$287,442 | $11.49 | 12 |
| 2022 Q1 | 288,838 | $14,552,000 | +$2,807,181 | $21.05 | 12 |
| 2021 Q4 | 350,882 | $9,128,546 | +$6,241,814 | $26.02 | 15 |
| 2021 Q3 | 100,046 | $2,694,095 | +$83,467 | $26.93 | 10 |
| 2021 Q2 | 96,442 | $3,618,998 | +$35,205 | $37.62 | 8 |
| 2021 Q1 | 91,480 | $4,164,729 | -$3,444,751 | $45.54 | 13 |
| 2020 Q4 | 198,403 | $6,269,391 | +$1,876,283 | $31.62 | 10 |
| 2020 Q3 | 171,660 | $3,176,000 | +$1,458,187 | $18.50 | 9 |
| 2020 Q2 | 93,006 | $1,168,000 | +$52,830 | $12.56 | 9 |
| 2020 Q1 | 88,858 | $814,000 | -$1,574,597 | $9.16 | 7 |
| 2019 Q4 | 216,569 | $2,564,000 | +$1,982,236 | $11.84 | 7 |
| 2019 Q3 | 49,115 | $403,000 | -$443,295 | $8.21 | 2 |
| 2019 Q2 | 89,055 | $980,000 | +$295,423 | $11.00 | 4 |
| 2019 Q1 | 62,500 | $822,000 | +$427,846 | $13.18 | 4 |
| 2018 Q4 | 29,910 | $241,000 | +$241,000 | $8.06 | 2 |
| 2016 Q2 | 0 | $0 | -$4,000 | $9.66 | 0 |
| 2016 Q1 | 300 | $4,000 | $13.33 | 1 |